Related Experiment Video
Updated: Jul 18, 2026
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Malignant glaucoma after phacoemulsification: treatment with diode laser cyclophotocoagulation.
Mahiul M K Muqit1, Mitchel J Menage
1Glaucoma Service, Department of Ophthalmology, Leeds General Infirmary, Great George Street, Leeds, United Kingdom.
Journal of Cataract and Refractive Surgery
|December 27, 2006
Summary
Transscleral diode laser cyclophotocoagulation effectively treated malignant glaucoma after phacoemulsification with intraocular lens implantation. This intervention normalized intraocular pressure and deepened the anterior chamber, offering a less risky alternative when medical therapy fails.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Cataract Surgery Complications
Background:
- A patient with ocular hypertension and narrow drainage angles underwent phacoemulsification with intraocular lens (IOL) implantation.
- Previous neodymium:YAG (Nd:YAG) laser peripheral iridotomy was performed.
- Temporal zonular weakness was noted during the uneventful phacoemulsification surgery.
Observation:
- Two months post-surgery, the patient developed malignant glaucoma with anterior IOL displacement.
- The IOL shift correlated with a significant myopic refractive error (-4.0 diopters).
- Medical treatment and Nd:YAG hyaloidotomy were ineffective in managing the condition.
Findings:
- Transscleral diode laser cyclophotocoagulation was administered as a single treatment.
- Intraocular pressure normalized within 48 hours post-procedure.
- The anterior chamber deepened, and the patient's condition remained stable for 3 months with improved visual acuity (6/9).
Implications:
- Transscleral diode laser cyclophotocoagulation presents a potentially effective and lower-risk alternative for managing malignant glaucoma when medical therapies fail.
- This approach may be a valuable option for complex cases following cataract surgery and IOL placement.
- Further research into diode laser cyclophotocoagulation for refractory malignant glaucoma is warranted.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...